What is Getlabs?
Founded in 2018, Getlabs operates at the intersection of medical logistics and patient-centric care. By integrating directly with major diagnostic providers such as Labcorp and Quest Diagnostics, the company removes the traditional friction associated with clinical testing. The platform provides a seamless digital interface for patients to schedule professional blood draws in the comfort of their homes, effectively transforming the diagnostic experience. This model addresses critical pain points in healthcare accessibility, particularly for patients with mobility constraints or those seeking to avoid the logistical burdens of traditional laboratory visits. As the healthcare industry shifts toward decentralized care models, Getlabs serves as a vital infrastructure layer, ensuring that diagnostic data remains accessible and actionable for both providers and patients.
How much funding has Getlabs raised?
Getlabs has raised a total of $23M across 2 funding rounds:
Angel/Seed
$3M
Series A
$20M
Angel/Seed (2021): $3M with participation from PivotNorth Capital
Series A (2022): $20M led by Emerson Collective and The Minderoo Foundation
Key Investors in Getlabs
PivotNorth Capital
Pivot North Capital is a venture capital firm that focuses on early-stage technology companies, providing strategic support to help innovative startups scale in competitive markets.
Emerson Collective
Emerson Collective is an investment organization that partners with purpose-driven entrepreneurs to address complex global challenges in education, economic mobility, and the environment.
The Minderoo Foundation
The Minderoo Foundation is a modern philanthropic organization that drives positive, lasting change through large-scale initiatives in health, ocean research, and community development.
What's next for Getlabs?
The infusion of capital from this major enterprise-level funding round provides Getlabs with the necessary resources to scale its phlebotomy network and enhance its technological infrastructure. Moving forward, the company is expected to focus on deepening its integration with existing diagnostic partners while potentially exploring new service verticals within the home-health ecosystem. By leveraging this recent financing, Getlabs aims to solidify its market position as a leader in the at-home diagnostic space, driving operational efficiency and expanding its geographic reach to meet the growing demand for convenient, high-quality medical services. The strategic backing from institutional investors suggests a long-term commitment to scaling this essential healthcare utility.
See full Getlabs company page
